Delivery Order SPE2DB24D2003-SPE2DB25FXCV4

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,121.16 firm fixed-price delivery order is for the supply of 4,566,177,920 units of Cimzia 2x200 mg/ml syringe kits. The award has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,530.53, is a Firm Fixed Price Delivery Order for the supply of CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CIMZIA 2X200 MG/ML syringe kits. The firm-fixed-price delivery order, valued at $6,125.66, has a completion date of November 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,984.58 firm-fixed-price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of January 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,560.58 firm fixed price delivery order is for the supply of 4,566,242,301 units of the CIMZIA 2X200 MG/ML syringe kits. This contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,256.11 firm fixed-price delivery order is for the supply of 4567645281 CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,679.42, is a Firm Fixed Price Delivery Order for the supply of CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $11,971.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CIMZIA 2X200 MG/ML Syringe Kits, with a performance period ending on November 14, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,468.00 fixed-price delivery order contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a performance period running through January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $20,195.33, is for the delivery of Cimzia 2x200 mg/ml syringe kits. This is a firm fixed-price delivery order contract with an ultimate completion date of December 18, 2023. The contract was not set aside for any specific type of business. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXCV4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,041.55 firm fixed-price delivery order is for the supply of Cimzia 2x200mg/mL syringe kits. The contract has an ultimate completion date of October 18, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The awarded contract does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 1/16/25, 9:11 AM